Arabic Arabic English English French French German German
dark

Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.

PMID: 

Minerva Med. 2021 Jun 28. Epub 2021 Jun 28. PMID: 34180638

Abstract Title: 

Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.

Abstract: 

AIM: The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients.RESULTS: 19 subjects with idiopathic interstitial pneumonia (IIP) were included in the study. High Resolution CT scans at inclusion confirmed the presence of lung fibrosis: 10 patients were treated with the Pycnogenol® Centellicum® combination and 9 subjects with standard management (SM) served as controls. Oxidative stress that was very high in all subjects at inclusion, decreased significantly in the supplement group (p

read more

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

This data suggest the therapeutic effect of allicin (L-cysteine) on COVID-19.

Next Post

The efficacy of black chokeberry fruits against cardiovascular diseases.

Related Posts
Total
0
Share